Prevalence of erectile dysfunction in patients consulting urological clinics: multi-centric survey in the algerian west

##plugins.themes.academic_pro.article.main##

Mahmoud Benatta
Nassim Kazi Tani
Sataa Sallami
K Belayachi
M Mahdid
M Lakli
Mohamed El Amin Djazouli
Mohamed Amin Djazouli

Abstract

 

SUMMARY:

Aim: The aim of this study was to make an inventory of the prevalence, the severity, the reasons for the patient’s consultation and the therapeutic measures indicated by urologists for erectile dysfunction (ED) in the west of Algeria.

Methods: This survey was conducted among 4 urologists. All male patients, aged over 18 years, presenting to clinics during the study period of 2 months were included. Data collection was based on a self-administered questionnaire on socio-demographic data, comorbidities especially urological and sexual health history. The evaluation of ED was achieved by the single question of John B. McKinlay. One more question was asked to evaluate trouble reported by the patient's partner.

Results: This survey included 185 patients. It showed a high prevalence of ED (59.5%), correlated with age. The mean age was 61 ± 13 years. Thirty four percent of patients had severe ED. The reason for consultation was dominated by prostatic diseases (70%), the ED accounted for only 9% of the reasons for consultation. Only 26% of patients reported having talked previously to a doctor about their ED. These disturbances were "unacceptable" for 25% of patients and "moderately acceptable" for 30%. A minority of patients (16%) was treated medically for their ED (half of them received PDE5 inhibitors alone or in combination).
Conclusion: This first survey in the urological Algerian community emphasizes the importance of sexual dysfunction in patients consulting in urology. Although the prevalence of ED is important, few patients consult specifically for this reason. As a result, treatment is limited. Better physician awareness of the problem of ED is recommended.

Keywords:

Epidemiology, Erectile dysfunction, General practitioner, sexual health, PDE5 Inhibitors, Algeria

##plugins.themes.academic_pro.article.details##

References

  1. Lue TF, Giuliano F, Montorsi F, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004;1:6-23.
  2. O'Donnell AB, Araujo AB, Goldstein I, et al. The validity of a single-question self-report of erectile dysfunction. Results from the Massachusetts Male Aging Study. J Gen Intern Med. 2005;20:515-9.
  3. Willke RJ, Glick HA, McCarron TJ,et al. Quality of life effects of alprostadil therapy for erectile dysfunction. J Urol. 1997;157:2124-8.
  4. Tardieu A, Khodari M, Palazzi J, et al. Attitudes des médecins généralistes et endocrinologues face à la dysfonction érectile du patient diabétique: enquête auprès de 130 patients. Prog Urol. 2011;21:126-33.
  5. Costa P, Avances C, Wagner L. Dysfonction érectile: connaissances, souhaits et attitudes. Résultats d'une enquête française réalisée auprès de 5.099 hommes âgés de 18 ans à 70 ans. Prog Urol. 2003;13:85-91.
  6. NIH Consensus Conference. Impotence. (Speakers included McKinlay JB, The prevalence and demographics of impotence). J Am Med Assoc. 1993;270:83-90.
  7. Trude S. So much to do, so little time: physician capacity constraints, 1997-2001. Track Rep. 2003;8:1-4.
  8. Rowland DL, Thornton JA, Burnett AL. Recognizing the risk of erectile dysfunction in a urology clinic practice. BJU Int. 2005;95:1034-8
  9. O'Leary MP, Lenderking WR, Barber B, et al. A brief male sexual function inventory for urology. Urology. 1995;46:697-706.
  10. Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822-30.
  11. Kleinman KP, Feldman HA, Johannes CB, et al. A new surrogate variable for erectile dysfunction status in the Massachusetts Male Aging Study. J Clin Epidemiol. 2000;53:71-8
  12. Giuliano F, Chevret-Measson M, Tsatsaris A, et al. Prevalence of erectile dysfunction in France: results of an epidemiological survey of a representative sample of 1004 men. Eur Urol. 2002;42:382-9.
  13. Rosen R, Altwein J, Boyle P, et al. Troubles urinaires du bas appareil et dysfonction sexuelle masculine: 'Enquête MSAM-7 ou Enquête Multinationale de l'Homme Agé. Prog Urol. 2004;14:332-44.
  14. Braun M, Wassmer G, Klotz T, et al. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res. 2000;12:305-11.
  15. McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res. 2000;12:S6-S11.
  16. Koskimäki J, Hakama M, Huhtala H, et al. Effect of erectile dysfunction on frequency of intercourse: a population based prevalence study in Finland. J Urol. 2000;164:367-70.
  17. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, et al. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol. 2001;166:569-74.
  18. Giuliano F, Chevret-Measson M, Tsatsaris A, et al. Prévalence de l'insuffisance érectile en France: résultats d'une enquête épidémiologique menée auprès d'un échantillon représentatif de 1004 hommes. Prog Urol. 2002;12:260-7.
  19. Desvaux P, Corman A, Hamidi K, et al. Prise en charge de la dysfonction érectile en pratique quotidienne : Etude PISTES. Prog Urol. 2004;14:512-20.
  20. Droupy S, Giuliano F, Cuzin B, et al. Enquête Menée en Partenariat avec l'Association Française d'Urologie (AFU). Prévalence de la dysfonction érectile chez les patients consultant en urologie: l'enquête ENJEU (Enquête nationale de type 1 Jour sur la prévalence de la dysfonction Érectile chez des patients consultant en urologie). Prog Urol. 2009;19:830-8.
  21. Mirone V, Gentile V, Zizzo G, et al. Did men with erectile dysfunction discuss their condition with partners and physicians? A survey of men attending a free call information service. Int J Impot Res. 2002;14:256-8.